AXL and hepatocellular carcinoma: Whilst a number of compensatory pathways, including EMT,23 have been highlighted as putative mechanistic drivers of sorafenib resistance, the role of Axl has not been addressed by the previous studies.24 We investigated the biologic relevance of Axl in the progression of HCC and in the acquisition of adaptive resistance to sorafenib.